Pegloticase
Horizon Therapeutics
[]
botson et al. 52 week results mirror trial. mtx added to pegloticase. 71% vs 39% su &lt;6mg/dl. infusion reaction 13% vs 32% if ab+ 0% vs 30% ab- #acr22 abstr#0001 #acrbest 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC